With our MosaiQ AiPlex Celiac Disease microarray already under review by the FDA, today's submission brings us a significant step closer to delivering clinical and economical value to customers in the ...

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial. Continuous MMAI scores ...